Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140
Clinical trial NCT02483078 · COMPLETED
Trial details
- NCT number
- NCT02483078
- Sponsor
- CytoDyn, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2018-02-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.